SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $27,833,526 | -1.1% | 1,061,538 | -2.9% | 0.03% | -5.7% |
| Q1 2023 | $28,142,829 | +99478.3% | 1,093,350 | +0.6% | 0.04% | -14.6% |
| Q4 2022 | $28,262 | -99.9% | 1,086,567 | -1.7% | 0.04% | -12.8% |
| Q3 2022 | $31,541,000 | +16.1% | 1,105,540 | +0.2% | 0.05% | +23.7% |
| Q2 2022 | $27,170,000 | -24.0% | 1,103,577 | +74.2% | 0.04% | -7.3% |
| Q1 2022 | $35,752,000 | -16.8% | 633,448 | -8.7% | 0.04% | -4.7% |
| Q4 2021 | $42,993,000 | +84.2% | 693,655 | +88.5% | 0.04% | +65.4% |
| Q3 2021 | $23,343,000 | – | 367,949 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |